International Flavors & Fragrances Inc. Reports Q3 2025 Results: Sales Decline Amid Strategic Restructuring
International Flavors & Fragrances Inc. (IFF), a prominent player in the global flavors and fragrances market, released its Q3 2025 financial results, revealing a notable decrease in sales and a significant reorganization of its operational structure. The report highlights both challenges and opportunities as the company navigates a changing market landscape and adjusts to recent divestitures.
1. Company Overview and Strategic Changes
Company Background
Founded in 1889, IFF is recognized as a leading creator and manufacturer of flavors, fragrances, and health solutions. With a diverse product portfolio serving sectors including food, beverage, health & biosciences, and personal care, IFF has maintained a strong global presence. The recent divestiture of its Pharma Solutions segment marks a significant pivot in its business strategy, allowing for a sharper focus on core sectors.
Organizational Restructuring
As of January 1, 2025, IFF implemented a major restructuring, creating five distinct reportable segments: Taste, Food Ingredients, Health & Biosciences, Scent, and Pharma Solutions. This initiative aims to enhance operational efficiency and better align the company’s offerings with market demands.
2. Financial Performance Overview
Sales Figures
During Q3 2025, IFF reported total sales of $2.694 billion, down $231 million or 8% from $2.925 billion in Q3 2024. On a comparable currency-neutral basis, sales remained flat, underpinned by favorable pricing and volume increases in the Scent and Taste segments. The divestiture of the Pharma Solutions and Nitrocellulose disposal groups led to a portfolio mix change, adversely affecting sales by approximately $282 million.
| Nov 2024 | Nov 2025 | |
|---|---|---|
Net Income | -2.32B | -412M |
Net Income to Non-controlling Interest | 5M | 2M |
Profit | -2.31B | -410M |
Net Income Continuing | -2.31B | -410M |
Income Tax Expense | 68M | -109M |
Pretax Income | -2.24B | -519M |
Non-operating Income | -351M | -167M |
Operating Income | -1.89B | -352M |
Revenue | 11.41B | 11.07B |
Costs and Expenses | 13.34B | 11.50B |
Cost of Revenue | 7.41B | 7.04B |
Operating Expenses | 5.93B | 4.45B |
Depreciation, Depletion & Amortization | 634M | 577M |
Impairment Expense | 2.71B | 1.57B |
Research & Development | 658M | 690M |
Restructuring Charge | 13M | 77M |
Selling, General & Administrative | 1.92B | 1.88B |
Other Operating Expenses | -13M | -345M |
Gross Profit and Operating Results
Gross profit for Q3 2025 stood at $983 million, a decrease of $69 million or 7%, representing 36.5% of sales. The decline is attributed to the altered business portfolio due to divestitures, although this was somewhat mitigated by improved net pricing and productivity gains.
Segment Performance
- Taste: Sales increased by $12 million (2%) to $635 million, primarily driven by price hikes.
- Food Ingredients: Sales decreased by $13 million (2%) to $830 million, mainly due to volume declines in specific units.
- Health & Biosciences: Sales rose by $9 million (2%) to $577 million, with flat performance on a comparable currency-neutral basis.
- Scent: Sales increased by $39 million (6%) to $652 million, fueled by higher volume in Fine Fragrance.
- Pharma Solutions: This segment reported no sales following its divestiture, which closed on May 1, 2025.
3. Cost and Expense Analysis
Cost of Sales and Operating Expenses
Cost of sales fell by $162 million to $1.711 billion, reflecting 63.5% of sales. Concurrently, research and development (R&D) expenses rose by $12 million to $174 million, driven by increased employee-related costs. Selling and administrative (S&A) expenses decreased by $74 million to $421 million, largely due to lower incentive compensation and consulting fees associated with the divestitures.
Restructuring Charges and Interest Expense
Restructuring charges increased to $16 million, indicating higher severance costs resultant from the IFF Productivity Program. Conversely, interest expenses decreased to $48 million due to reduced outstanding debt levels.
4. Income Tax and Net Income
The effective tax rate for Q3 2025 was 26.8%, down from 37.9% in the previous year, largely due to tax impacts from the divestitures. Net income to common shareholders was reported at $40 million, a decline from $59 million in Q3 2024.
| Nov 2024 | Nov 2025 | |
|---|---|---|
Total Assets | 29.92B | 25.76B |
Total Current Assets | 8.42B | 5.87B |
Cash and Equivalents | 567M | 621M |
Net Inventories | 2.2B | 2.32B |
Other Current Assets | 3.88B | 1.06B |
Total Non-current Assets | 21.50B | 19.89B |
Intangible Assets | 16.11B | 14.44B |
Net PP&E | 3.77B | 3.86B |
Lease Assets | 646M | 595M |
Other Non-current Assets | 968M | 982M |
Total Liabilities and Equity | 29.92B | 25.76B |
Total Liabilities | 15.11B | 11.49B |
Total Current Liabilities | 3.21B | 4.06B |
Accounts Payable and Accrued Liabilities | 1.69B | 1.67B |
Current Debt | 468M | 1.30B |
Other Current Liabilities | 1.05B | 1.08B |
Total Non-current Liabilities | 11.9B | 7.42B |
Long-term Debt | 8.63B | 4.74B |
Non-current Deferred Tax Liabilities | 1.86B | 1.34B |
Other Non-current Liabilities | 1.4B | 1.34B |
Total Equity and Non-controlling Interests | 14.81B | 14.27B |
Total Equity | 14.77B | 14.24B |
Non-controlling Interests | 35M | 32M |
5. Liquidity and Cash Flow
Cash and Cash Equivalents
As of September 30, 2025, IFF held cash and cash equivalents of $621 million, a rise from $471 million at the end of 2024.
Cash Flow Analysis
Operating activities yielded cash flows of $532 million for the nine months ending September 30, 2025, albeit a decrease from $681 million in the prior year. Notably, cash flows from financing activities surged to $2.891 billion, driven by the repurchase of outstanding senior notes.
6. Conclusion
IFF’s Q3 2025 financial results underscore the complexities of navigating a rapidly evolving market amid strategic restructuring. While the company faces challenges with declining sales and portfolio changes, it remains committed to enhancing its growth prospects through targeted investments and a focus on core segments. As IFF continues to adapt, it aims to leverage its strong liquidity and capital resources to drive future innovation and maintain its competitive edge in the flavors and fragrances industry.
